References
- Abozguia K, Chudley S, Gammage M. (2006). Dose-dependent Venlafaxine-induced sinus tachycardia. Int J Cardiol113: E9–10.10.1016/j.ijcard.2006.01.072
- Alosaimi FD, Abalhassan M, Alhaddad B, Alzain N, Fallata E, Alhabbad A, Alassiry MZ. (2017). Prevalence of metabolic syndrome and its components among patients with various psychiatric diagnoses and treatments: A cross-sectional study. Gen Hosp Psychiatry45: 62–69.10.1016/j.genhosppsych.2016.12.007
- Bavle A. (2015). Venlafaxine induced QTc interval prolongation in a therapeutic dose. Asian J Psychiatr16: 63–64.10.1016/j.ajp.2015.06.001
- Bilora F, Vettore G, Barbata A, Pastorello M, Petrobelli F, San Lorenzo I. (1999). Electrocardiographic findings in obese subjects. Minerva Gastroenterol Dietol45: 193–197.
- Burke V, Beilin LJ, Cutt HE, Mansour J, Wilson A, Mori TA. (2005). Effects of a lifestyle programme on ambulatory blood pressure and drug dosage in treated hypertensive patients: a randomized controlled trial. J Hypertens23: 1241–9.10.1097/01.hjh.0000170388.61579.4f
- Delbosc S, Paizanis E, Magous R, Araiz C, Dimo T, Cristol JP, Cros G, Azay J. (2005). Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis179: 43–49.10.1016/j.atherosclerosis.2004.10.018
- Dupas J, Feray A, Goanvec C, Guernec A, Samson N, Bougaran P, Guerrero F, Mansourati J. (2017). Metabolic Syndrome and Hypertension Resulting from Fructose Enriched Diet in Wistar Rats. Biomed Res Int2017: 2494067.10.1155/2017/2494067
- Elezaby A, Sverdlov AL, Tu VH, Soni K, Luptak I, Qin F, Liesa M, Shirihai OS, Rimer J, Schaffer JE, Colucci WS, Miller EJ. (2015). Mitochondrial remodeling in mice with cardiomyocyte-specific lipid overload. J Mol Cell Cardiol79: 275–283.10.1016/j.yjmcc.2014.12.001
- Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index). (2011). National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet377: 557–567.10.1016/S0140-6736(10)62037-5
- Flegal KM, Graubard BI, Williamson DF, Gail MH. (2007). Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA298: 2028–2037.10.1001/jama.298.17.2028
- Gancheva S, Galunska B, Zhelyazkova-Savova M. (2017). Diets rich in saturated fat and fructose induce anxiety and depression-like behaviors in the rat: is there a role for lipid peroxidation? Int J Exp Pathol98: 296–306.10.1111/iep.12254574378729210119
- Gariepy G, Nitka D, Schmitz N. (2010). The association between obesity and anxiety disorders in the population: a systematic review and meta-analysis. Int J Obes (Lond)34: 407–419.10.1038/ijo.2009.252
- Gradel AKJ, Salomonsson M, Sørensen CM, Holstein-Rathlou NH, Jensen LJ. (2018). Long-term diet-induced hypertension in rats is associated with reduced expression and function of small artery SKCa, IKCa, and Kir2.1 channels. Clin Sci (Lond)132: 461–474.10.1042/CS20171408
- Harvey AT, Rudolph RL, Preskorn SH. (2000). Evidence of the dual mechanisms of action of venlafaxine. Arch Gen Psychiatry57: 503–509.10.1001/archpsyc.57.5.503
- Hinderliter AL, Sherwood A, Craighead LW, Lin PH, Watkins L, Babyak MA, Blumenthal JA. (2014). The long-term effects of lifestyle change on blood pressure: One-year follow-up of the ENCORE study. Am J Hypertens 27: 734–741.10.1093/ajh/hpt183
- Howarth FC, Jacobson M, Shafiullah M, Adeghate E. (2008). Long-term effects of type 2 diabetes mellitus on heart rhythm in the Goto-Kakizaki rat. Exp Physiol93: 362–369.10.1113/expphysiol.2007.040055
- Cheng S-M, Cheng Y-J, Wu L-Y, Kuo C-H, Lee Y-S, Wu M-C, Huang C-Y, Ting H, Lee S-D. (2014). Activated apoptotic and anti-survival effects on rat hearts with fructose induced metabolic syndrome. Cell Biochem Funct32: 133–141.10.1002/cbf.2982
- Jover B, Reynes C, Rugale C, Reboul C, Jeanson L, Tournier M, Lajoix AD, Desmetz C. (2017). Sodium restriction modulates and prevents cardiac remodeling in a rat model of Metabolic syndrome. Biochim Biophys Acta Mol Basis Dis1863: 1568–1574.10.1016/j.bbadis.2017.02.026
- Kaprinay B, Lipták B, Slovák L, Švík K, Knezl V, Sotníkoví R, Gáspárová Z. (2016). Hypertriglyceridemic rats fed high fat diet as a model of metabolic syndrome. Physiol Res65: S515–S518.10.33549/physiolres.933524
- Kaprinay B, Gáspárová Z, Lipták B, Frimmel K, Sotníková R. (2017). Endothelial dysfunction in experimental models of metabolic syndrome - effect of fructose. Eur Pharm J64: 4–6.10.1515/afpuc-2017-0014
- Khalifa M, Daleau P, Turgeon J. (1999). Mechanism of sodium channel block by venlafaxine in guinea pig ventricular myocytes. J Pharmacol Exp Ther291: 280–284.
- Khurana RN, Baudendistel TE. (2003). Hypertensive crisis associated with venlafaxine. Am J Med115: 676–677.10.1016/S0002-9343(03)00472-8
- Kıvrak Y, Güvenç TS, Akbulut N, Yağcı I, Çığşar G, Gündüz S, Balcı B. (2014). Accelerated Hypertension after Venlafaxine Usage. Case Rep Psychiatry2014: 659715.10.1155/2014/659715
- Knezl V, Sotní ková R, Brnoliaková Z, Stankovič ová T, Bauer V, Bezek Š. (2017). Monotherapy of experimental metabolic syndrome: II. study of cardiovascular effects. Interdiscip Toxicol10: 86–92.10.1515/intox-2017-0014
- Kurl S, Laaksonen DE, Jae SY, Makikallio TH, Zaccardi F, Kauhanen J, Ronkainen K, Laukkanen JA. (2015). Metabolic syndrome and the risk of sudden cardiac death in middle-aged men. Int J Cardiol203: 792–797.10.1016/j.ijcard.2015.10.218
- Letsas K, Korantzopoulos P, Pappas L, Evangelou D, Efremidis M, Kardaras F. (2006). QT interval prolongation associated with venlafaxine administration. Int J Cardiol109: 116–117.10.1016/j.ijcard.2005.03.065
- Li W, Bai Y, Sun K, Xue H, Wang Y, Song X, Fan X, Song H, Han Y, Hui R. (2009). Patients with metabolic syndrome have prolonged corrected QT interval (QTc). Clin Cardiol32: E93–99.10.1002/clc.20416
- Lipták B, Kaprinay B, Gáspárová Z. (2017a). A rat-friendly modification of the non-invasive tail-cuff to record blood pressure. Lab Animal46: 251–253.10.1038/laban.127228530692
- Mbaya P, Alam F, Ashim S, Bennett D. (2007). Cardiovascular effects of high dose venlafaxine XL in patients with major depressive disorder. Human Psychopharmacology22: 129–133.10.1002/hup.834
- McIntyre RS, Young Park K, Law CWY, Sultan F, Adams A, Lourenco MT, Lo AKS, Soczynska JK, Woldeyohannes H, Alsuwaidan M, Yoon J, Kenedy SH. (2010). The association between conventional antidepressants and the metabolic syndrome. CNS Drugs24: 741–753.10.2165/11533280-000000000-00000
- Moro C, Cosío FG. (1980). Electrophysiologic study of patients with short P-R interval and normal QRS complex. Eur J Cardiol11: 81–90.
- Pan A, Keum N, Okereke OI, Sun Q, Kivimaki M, Rubin RR, Hu FB. (2012). Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care 35: 1171–1180.10.2337/dc11-2055
- Sasváriová M, Tyukos-Kaprinay B, Salvaras L, Belovičová K, Bögi E, Knezl V, Barteková M, Stankovičová T, Dubovický M. (2018). Effect of pre-gestational stress and prenatal venlafaxine administration on cardiovascular system of rat offspring. Eur Pharm J65: 17–22.10.2478/afpuc-2018-0007
- Schumacher K, Büttner P, Dagres N, Sommer P, Dinov B, Hindricks G, Bollmann A, Kornej J. (2018). Association between PR interval prolongation and electro-anatomical substrate in patients with atrial fibrillation. PLoS One13: e0206933.10.1371/journal.pone.0206933
- Simon GE, Von Korff M, Saunders K, Miglioretti DL, Crane PK, van Belle G, Kessler RC. (2006). Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry63: 824–830.10.1001/archpsyc.63.7.824
- Toscano AE, Amorim MA, de Carvalho Filho EV, Aragão Rda S, Cabral-Filho JE, de Moraes SR, Manhaes-de-Castro R. (2008). Do malnutrition and fluoxetine neonatal treatment program alterations in heart morphology? Life Sci82: 21–22.10.1016/j.lfs.2008.03.01318445498
- van de Weijer T, Schrauwen-Hinderling VB, Schrauwen P. (2011). Lipotoxicity in type 2 diabetic cardiomyopathy. Cardiovasc Res92: 10–18.10.1093/cvr/cvr212
- Vicen M, Gulač P, Stankovičová T. (2016). Changes in electrical activity of heart during ischemic-reperfusion injury modified by the administration of antidepressants. Eur Pharm J1: 5–8.10.1515/afpuc-2016-0006
- Vancampfort D, Correll CU, Wampers M, Sienaert P, Mitchaell AJ, De Herdt A, Probst M, Scheewe W, De Hert M. (2014). Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalence and moderating variables. Psychol Med44: 2017–2028.10.1017/S0033291713002778
- Watanabe H., Tanabe N, Watanabe T, Roden D M, Sasaki S. (2008). Aizawa Y. Metabolic syndrome and risk of development of atrial fibrillation. Circulation117: 1255–1260.10.1161/CIRCULATIONAHA.107.744466
- Wong SK, Chin KY, Suhaimi FH, Ahmad F, Ima-Nirwana S. (2018). The Effects of a Modified High-carbohydrate High-fat Diet on Metabolic Syndrome Parameters in Male Rats. Exp Clin Endocrinol Diabetes 126: 205–212.10.1055/s-0043-119352
- Yang Q, Kiyoshige K, Fujimoto T, Katayama M, Fujino K, Saito K, Nakaya Y, Mori H. (1990). Signal-averaging electrocardiogram in patients with diabetes mellitus. Jpn Heart J31: 25–33.10.1536/ihj.31.25
- Yilmaz H1, Özcan KS, Sayar N, Kemaloglu T, Gungor B, Erer B, Yilmaz M, Gurkan U, Cakmak N, Oz D, Calik AN, Bolca O. (2015). Metabolic syndrome is associated with atrial electrical and mechanical dysfunction. Med Princ Pract24: 147–152.10.1159/000368754